Drug profile · INN
dantrolene
DANTRIUM
dantrolene (DANTRIUM) is a ryanodine receptor 3 antagonist. Associated with Pfizer Australia Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — dantrolene
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.81
Quick answer
dantrolene (DANTRIUM) is a ryanodine receptor 3 antagonist. Associated with Pfizer Australia Pty Ltd.
Key facts
INN dantrolene
Brand DANTRIUM
Mechanism Ryanodine receptor 3 antagonist
Originator Pfizer Australia Pty Ltd
Mechanism of action
Ryanodine receptor 3 antagonist
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is dantrolene?
dantrolene (DANTRIUM) is a ryanodine receptor 3 antagonist. Associated with Pfizer Australia Pty Ltd.
What is the brand name for dantrolene?
DANTRIUM is a marketed brand name for dantrolene. Check FDA Drugs@FDA for the current US label holder and prescribing information.